Biotech

All Articles

Lundbeck signs $2.5 B check for Longboard and its own epilepsy med

.After spying runaway success capacity in Longboard Pharmaceuticals' epilepsy med, brain disease-foc...

Lilly selects UK for 1st Entrance Lab in Europe

.Eli Lilly's Entrance Labs is actually going global, with the U.K. authorities announcing today that...

Jasper dials up dose after hives actions reoccur rapidly

.Jasper Therapeutics has actually disclosed total responses in 10 of the 12 chronic colonies clients...

Transgene's popular cancer vaccine fails midphase exam

.Transgene's restorative vaccine candidate TG4001 has flunked a phase 2 solid lump test. But, while ...

Upstream swells IPO to $255M as it lists along with CAMP4

.Upstream Bio has swollen its own IPO to $255 million as the company signs up with CAMP4 Rehabs this...

Sanofi flunks MS research, dealing another strike to Denali deal

.Sanofi has actually quit a phase 2 difficulty of Denali Therapeutics-partnered oditrasertib in a nu...

Turnstone gives up 60%, shakes up C-suite to stretch out cash

.Turnstone Biologics is actually decreasing its headcount by 60% and also shaking up its C-suite so ...

Gilead gives up on $15M MASH wager after mulling preclinical records

.In a year that has actually seen a confirmation and a plethora of readouts for metabolic dysfunctio...

Texas biotech axes cancer cells deal, pins really hopes on being overweight

.Alaunos Therapeutics is axing an arrangement with Precigen, surrendering licensing civil liberties ...

Capricor reveals extra information for DMD treatment after triggering BLA

.Capricor Rehabs is actually taking a success lap for their stage 2 Duchenne muscle dystrophy (DMD) ...